Welcome to our dedicated page for Amrize SEC filings (Ticker: AMRZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Amrize Ltd filings document a Swiss-incorporated North American building-solutions company with ordinary shares listed on the New York Stock Exchange and SIX Swiss Exchange. The company’s SEC reports include Form 8-K disclosures for quarterly and annual financial results, Regulation FD investor materials, dividend-related events, auditor changes, and board or executive appointments.
Proxy and annual meeting filings cover shareholder voting, board elections, compensation matters, distributions from legal reserves from capital contributions, and governance procedures under the company’s Swiss corporate structure. The filing record also documents Amrize’s completed spin-off from Holcim and related public-company reporting matters.
Amrize Ltd has called its 2026 Annual General Meeting for April 21, 2026 in Zug, Switzerland, asking shareholders to vote on a wide slate of financial, compensation and governance items. Shareholders are asked to approve the 2025 Annual Report, including Consolidated and Statutory Financial Statements, and an offset of accumulated losses totaling USD 102,256,906 using legal retained earnings and capital reserves.
The Board proposes a special one‑time cash distribution of USD 0.44 per outstanding share from capital contribution reserves and a regular dividend of up to USD 0.44 per share in up to four installments, capped at an aggregate USD 250,657,000. Advisory votes cover U.S.‑style say‑on‑pay, Swiss statutory remuneration, a Non‑Financial Matters Report on environmental and social topics, and the preferred annual frequency of say‑on‑pay.
Binding votes include discharging directors and executives from liability for 2025, re‑electing nine current directors and electing two new ones for one‑year terms, re‑electing Jan Jenisch as Chairman, choosing Compensation Committee members, and approving maximum aggregate compensation of USD 3,600,000 for the Board (2026–2027 term) and USD 59,000,000 for Executive Management for fiscal 2027. Shareholders are also asked to re‑elect Ernst & Young AG as statutory auditor, ratify Ernst & Young LLP as U.S. auditor for 2026, and appoint Advoro Zurich Ltd as Independent Voting Representative, alongside detailed instructions on record dates, proxy voting and meeting attendance.
Amrize Ltd executive Jaime Hill, President, Building Materials, bought 1,000 Ordinary Shares in an open-market transaction at $56.90 per share. After this purchase, Hill directly owns 28,000 Ordinary Shares, indicating a modest increase in personal equity exposure to the company.
Amrize Ltd's Chief Financial Officer, Ian A. Johnston, bought ordinary shares in the company in an open-market transaction. He acquired 4,250 ordinary shares at a price of $58.935 per share. Following this purchase, he directly owns 25,110 ordinary shares of Amrize Ltd.
Amrize Ltd executive Jaime Hill, President, Building Materials, bought 1,000 Ordinary Shares in an open-market purchase. The shares were acquired at a price of $58.91 per share. Following this transaction, Hill directly owns a total of 27,000 Ordinary Shares of Amrize.
Amrize Ltd Chief Technology Officer Roald Brouwer bought 3,000 Ordinary Shares in an open‑market purchase at $58.72 per share. After this transaction, he directly owns 16,257 Ordinary Shares.
According to a footnote, the purchase price was CHF 45.72 per share, converted into U.S. dollars using a transaction‑date exchange rate of USD 1.00 = CHF 0.7786.
Amrize Ltd executive Jaime Hill, President, Building Materials, purchased 3,184 Ordinary Shares in an open-market transaction at $56.34 per share. After this buy, Hill directly owns 26,000 Ordinary Shares. This filing shows an increase in the executive’s personal stake in the company.
Amrize Ltd Chairman & CEO Jan Philipp Jenisch reported an open-market purchase of 60,000 Ordinary Shares on March 6, 2026 at an average price of $58.05 per share. After this trade, his directly held stake rose to 1,703,582 Ordinary Shares.
A footnote explains the buy was executed in multiple trades between CHF 45.30 and CHF 45.50, with a weighted average price of CHF 45.39, converted using an exchange rate of USD 1.00 = CHF 0.7819. He also reports 505,000 Ordinary Shares held indirectly through his spouse.
Amrize Ltd reported that Chief Strategy & M&A Officer Samuel Jonas Poletti acquired 4,256 ordinary shares on a grant/award basis at no cost. The shares were issued upon settlement of performance stock units originally granted under Holcim Ltd equity awards converted in connection with the Amrize spin-off. Following this settlement, his directly held stake increased to 7,645 ordinary shares.
Amrize Ltd reported that Chief Technology Officer Roald Brouwer acquired 4,257 ordinary shares on a grant or award basis at a stated price of $0.00 per share. After this settlement, his directly held stake totals 13,257 ordinary shares.
The new shares reflect settlement of performance stock units that originated from Holcim Ltd equity incentives, which were converted in connection with the June 23, 2025 spin-off of Amrize from Holcim. These units vested based on the performance of Holcim and Amrize over the period from January 1, 2023 through December 31, 2025.